- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Waltham Today
By the People, for the People
Vicarious Surgical Faces NYSE Delisting Again
Surgical robot developer's stock suspended after falling below $15 million market cap threshold
Published on Mar. 5, 2026
Got story updates? Submit your updates here. ›
Vicarious Surgical, a Massachusetts-based surgical robot developer, has received a notice from the New York Stock Exchange (NYSE) that it is commencing the process of delisting the company's stock. This is due to Vicarious Surgical's market capitalization falling below the required $15 million threshold for continued listing on the exchange. The company has 10 business days to appeal the decision and is currently evaluating its options, including having its stock quoted on the OTCID market tier.
Why it matters
Vicarious Surgical's potential delisting from the NYSE comes at a critical time for the company, which has been working to advance its surgical robotic platform. The company has faced various delays and setbacks in bringing its technology to market, and this latest development adds further uncertainty to its future. The delisting could impact the company's ability to raise capital and attract investors, potentially hindering its efforts to commercialize its surgical robot.
The details
Vicarious Surgical's stock was suspended from trading on the NYSE after market close on March 3, 2026, following the exchange's determination that the company's stock fell below the continued listing standard. The company must now make an appeal within 10 business days to avoid delisting. In the meantime, Vicarious Surgical has received approval to have its stock quoted on the OTCID market tier operated by the OTC Markets Group, and expects its common stock to begin trading on that market at the open of business today, March 4, 2026.
- On March 3, 2026, the NYSE commenced the process of delisting Vicarious Surgical's stock.
- Vicarious Surgical has 10 business days to appeal the NYSE's decision.
The players
Vicarious Surgical
A Massachusetts-based surgical robot developer that has been working to advance its robotic platform for surgical procedures.
New York Stock Exchange (NYSE)
The stock exchange that has determined Vicarious Surgical's market capitalization fell below the required $15 million threshold for continued listing.
OTC Markets Group
The operator of the OTCID market tier, where Vicarious Surgical's stock will be quoted after being suspended from the NYSE.
What’s next
Vicarious Surgical has 10 business days to appeal the NYSE's decision to delist its stock. If the company is unsuccessful in its appeal, its stock will be delisted from the NYSE and begin trading on the OTCID market tier.
The takeaway
Vicarious Surgical's potential delisting from the NYSE highlights the challenges the company has faced in commercializing its surgical robot technology. The loss of its NYSE listing could further hinder the company's efforts to raise capital and attract investors, potentially jeopardizing its long-term prospects.
